Exact Mass: 647.2856032

Exact Mass Matches: 647.2856032

Found 18 metabolites which its exact mass value is equals to given mass value 647.2856032, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Beiwutine

[(1R,2S,3S,4R,5R,6S,7S,8S,9R,13R,14R,16S,17R,18R)-8-Acetyloxy-2,5,7,14-tetrahydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] benzoate

C33H45NO12 (647.294161)


Beiwutine is a benzoate ester. Beiwutine is a natural product found in Aconitum kusnezoffii with data available. Beiwutine (10-Hydroxy mesaconitine) is a diester diterpenoid alkaloid[1]. Beiwutine (10-Hydroxy mesaconitine) is a diester diterpenoid alkaloid[1].

   

Ala Trp Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C36H37N7O5 (647.2856032)


   

Trp Ala Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C36H37N7O5 (647.2856032)


   

Trp Trp Ala Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]propanamido]-3-(1H-indol-3-yl)propanoic acid

C36H37N7O5 (647.2856032)


   

Trp Trp Trp Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]propanoic acid

C36H37N7O5 (647.2856032)


   

Lercanidipine hydrochloride

Lercanidipine hydrochloride

C36H42ClN3O6 (647.2761982)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-14-hydroxydocosa-4,7,9,11,16,19-hexaenoate

(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-14-hydroxydocosa-4,7,9,11,16,19-hexaenoate

C32H45N3O9S-2 (647.287636)


   

Protectin conjugate in tissue regeneration 1(2-)

Protectin conjugate in tissue regeneration 1(2-)

C32H45N3O9S-2 (647.287636)


   
   

(13R)-S-glutathionyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(2-)

(13R)-S-glutathionyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate(2-)

C32H45N3O9S (647.287636)


A docosanoid anion obtained by deprotonation of the three carboxy groups and protonation of the glutamyl alpha-amino group of (13R)-S-glutathionyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid; major species at pH 7.3.

   

16(S)-glutathionyl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(2-)

16(S)-glutathionyl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoate(2-)

C32H45N3O9S (647.287636)


A docosanoid anion obtained by deprotonation of the three carboxy groups and protonation of the glutamyl alpha-amino group of 16(S)-glutathionyl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid; major species at pH 7.3.

   
   

8-(acetyloxy)-2,5,7,14-tetrahydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

8-(acetyloxy)-2,5,7,14-tetrahydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C33H45NO12 (647.294161)


   

(1r,2s,3s,4r,5r,6s,7s,8s,9r,10r,13r,14r,16s,17r,18r)-8-(acetyloxy)-2,5,7,14-tetrahydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

(1r,2s,3s,4r,5r,6s,7s,8s,9r,10r,13r,14r,16s,17r,18r)-8-(acetyloxy)-2,5,7,14-tetrahydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C33H45NO12 (647.294161)


   

{[(2r,3s,5s,6r,7s,8z,10s,11s,12z,14z)-16,22,26-trihydroxy-2,5,6,11-tetramethoxy-3,7,9,15-tetramethyl-20-thia-17,23-diazatricyclo[16.7.1.0¹⁹,²⁴]hexacosa-1(25),8,12,14,16,18(26),19(24),22-octaen-10-yl]oxy}methanimidic acid

{[(2r,3s,5s,6r,7s,8z,10s,11s,12z,14z)-16,22,26-trihydroxy-2,5,6,11-tetramethoxy-3,7,9,15-tetramethyl-20-thia-17,23-diazatricyclo[16.7.1.0¹⁹,²⁴]hexacosa-1(25),8,12,14,16,18(26),19(24),22-octaen-10-yl]oxy}methanimidic acid

C32H45N3O9S (647.287636)


   

({22,26-dihydroxy-2,5,6,11-tetramethoxy-3,7,9,15-tetramethyl-16-oxo-20-thia-17,23-diazatricyclo[16.7.1.0¹⁹,²⁴]hexacosa-1(25),8,12,14,18(26),19(24),22-heptaen-10-yl}oxy)methanimidic acid

({22,26-dihydroxy-2,5,6,11-tetramethoxy-3,7,9,15-tetramethyl-16-oxo-20-thia-17,23-diazatricyclo[16.7.1.0¹⁹,²⁴]hexacosa-1(25),8,12,14,18(26),19(24),22-heptaen-10-yl}oxy)methanimidic acid

C32H45N3O9S (647.287636)


   

{[(2r,3s,5s,6r,7s,8e,10s,11s,12z,14e)-16,22,26-trihydroxy-2,5,6,11-tetramethoxy-3,7,9,15-tetramethyl-20-thia-17,23-diazatricyclo[16.7.1.0¹⁹,²⁴]hexacosa-1(25),8,12,14,16,18(26),19(24),22-octaen-10-yl]oxy}methanimidic acid

{[(2r,3s,5s,6r,7s,8e,10s,11s,12z,14e)-16,22,26-trihydroxy-2,5,6,11-tetramethoxy-3,7,9,15-tetramethyl-20-thia-17,23-diazatricyclo[16.7.1.0¹⁹,²⁴]hexacosa-1(25),8,12,14,16,18(26),19(24),22-octaen-10-yl]oxy}methanimidic acid

C32H45N3O9S (647.287636)


   

(1r,2s,3s,4r,5r,6s,7s,8s,13r,14r,16s,17r,18r)-8-(acetyloxy)-2,5,7,14-tetrahydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

(1r,2s,3s,4r,5r,6s,7s,8s,13r,14r,16s,17r,18r)-8-(acetyloxy)-2,5,7,14-tetrahydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C33H45NO12 (647.294161)